CALL FOR PROPOSALS
Deadline: February 16, 2018 (before MIDNIGHT)
Program: The Wallace H. Coulter Foundation provides funding to support collaborative translational research projects that involve co-principal investigators from the Department of Bioengineering and a clinical department in the School of Medicine. The goal of this program is to encourage research that addresses unmet clinical needs and leads to improvements in health care and to commercial products. Examples of desirable outcomes include inventions, patents, improved diagnosis and treatment of disease, commercial products, licenses, commercial partnerships and startup companies.
Eligibility: Each proposal must have at least two co-principal investigators
- one with a full, joint, or courtesy UTL, MCL, and NTL-Research faculty appointment in the Department of Bioengineering at Stanford
- and at least one with a full, joint, or courtesy UTL, MCL, NTL-Research or Clinician Educator faculty appointment in a clinical department in the School of Medicine
- other team members (grad students, postdocs, research staff, etc.) may be listed on the proposal
- A PDRF is not due at the time of proposal submission, however, in the event the proposal advances to the finalist screening stage, a PDRF will be required prior to the finalist presentations in March, 2018.
- Funding will not be dispersed without clearance of any applicable APLAC, IRB or IRB exemption requirements.
Criteria: The research must relate directly to applications in healthcare, and the objectives of the project should include an outcome that will benefit patients. Evaluation of proposals will be on the basis of innovation and scientific merit, potential health care impact, technical feasibility and the potential for commercialization. Award recipients will be required to prepare brief written quarterly progress reports and to present a mid-year project update to the Coulter Oversight Committee in early December.
Submission: We strongly encourage applicants to discuss their proposal with Coulter Program Director Gordon Saul (firstname.lastname@example.org) before submission. Please submit one PDF file following the guidelines and required content listed below via email attachment to: Coulter Program Manager, Linda Lucian (email@example.com) by 8:00pm on February 16, 2018
Submit file name as: Last name BioE PI_Last name SoM PI_2018Coulter
If the proposal is promising, applicants will be invited to present to the Coulter Committee on the afternoon of April 10th, 2018. The committee will review those presentations and make recommendations on funding priority. Applicants will be notified by mid-April for funding to begin in mid-May, 2018. Note that release of funds is dependent on appropriate IRB or APLAC approval. This approval process should be initiated or even finalized during the selection period in order to avoid delays should your proposal be selected for an award.
Format: Full proposals should include:
1) cover page: name of this RFP: Stanford-Coulter Translational Research Grant, project title, names and contact information of the co-principal investigators, funding amount requested, one-paragraph summary, approval/signature of the department chair of the School of Medicine co-investigator.
2) body of proposal: summary of the base technology, description of the product or service to be developed and a translational plan of the milestones, timing, and cost to bring the product or service to market (further details below). Include approval number from IRB or APLAC for any studies involving human or animal subjects. If not applicable, an exemption letter from the IRB must be submitted.
Content details: The grant proposal should not exceed 5 pages (≥ 0.5” margins, font equivalent to Times New Roman 12pt), excluding cover page, funding/pending proposal list, CVs and budget. It must include the following components (proposals will be rejected if any component is missing):
- Explanation of clinical importance of project (e.g., clinical need, envisioned product)
- Technology status, test results, prototypes
- Status of intellectual property, description of ongoing IP strategy
- A statement of risk analysis for each: a) clinical need b) engineering/science feasibility c) intellectual property d) business/market
- Expected specific milestones (per quarter) and research plan for achieving them
- Plan for funding after Coulter award expires
- Also address or include the following:
- Any approvals for animals and human subjects should be addressed ahead of the grant-funding period
- List of current funding related to this project, including internal seed grants obtained and pending proposals for each co-principal investigator
- If the project has not already been disclosed to the Office of Technology Licensing (OTL), it is strongly recommended that an Invention and Technology Disclosure be submitted to OTL by the February 15th deadline. See the Inventor Disclosure page located on the OTL site.
3) Budge Page (further details below)
4) two-page CV of co-principal investigators (you may also include the CVs of team members, not required)
5) relevant literature references
Duration: Grants will be for a one-year period and may be submitted for renewal the following year. Renewal applications must have a comparison of milestones achieved vs. those planned in the original submission. Renewal applications will be evaluated on a competitive basis with new applications. No Cost Extensions may be applied for by using this form.
Budgets: Grants may be requested for up to $100,000 direct costs for one year. Funds may be used for salary support of graduate students and other research staff, but may not be used for general staff, administrative support or tuition. Operating supplies, equipment items, prototyping expenses, imaging time and travel directly associated with the research activity are examples of eligible budget items. Budget details should include general categories such as personnel, supplies, travel, non-capital equipment and other project related expenses. Submit using Budget Page template.
Questions? Please contact Coulter Program Director Gordon Saul: firstname.lastname@example.org.